What is AtriCure's increase (decrease) in accounts receivable?

AtriCure (ATRC) reported increase (decrease) in accounts receivable of $5.02M in Q1 2026.

How has AtriCure's increase (decrease) in accounts receivable changed year-over-year?

AtriCure's increase (decrease) in accounts receivable increased by 86.9% year-over-year, from $2.69M to $5.02M.

AtriCure ATRC Increase (Decrease) in Accounts Receivable

Increase (Decrease) in Accounts Receivable at other companies

Avanos MedicalAVNS

$300K+101%

Pulse Biosciences, Inc.PLSE

——

Other financials

Income statement

See full

Revenue$141.2M+14.3%

Gross profit$109.3M+18.0%

Operating income$526.0K+109%

Net income$108.0K+102%

EPS (diluted)$0.00+100%

Balance sheet

See full

Cash & equivalents$146.2M+46.3%

Total debt$76.2M-3.1%

Total equity$491.7M+8.2%

Total assets$644.0M+8.8%

Cash flow

See full

Operating cash flow-$4.0M+63.8%

CapEx$3.9M+76.6%

Free cash flow-$7.8M+40.6%

Valuation

See full

Market cap$1.43B-9.9%

Enterprise value$1.36B-13.1%

P/S2.6×-0.7×

Profitability

See full

Gross margin75.6%+0.8pp

Operating margin-5.1%-1.3pp

Net margin-5.6%-1.5pp

FCF margin9.7%—

Returns & leverage

See full

Return on equity-6.1%-1.3pp

Debt / equity0.2×0.0×

Current ratio4.3×+0.2×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's increase (decrease) in accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AtriCure's increase (decrease) in accounts receivable?: AtriCure (ATRC) reported increase (decrease) in accounts receivable of $5.02M in Q1 2026.
How has AtriCure's increase (decrease) in accounts receivable changed year-over-year?: AtriCure's increase (decrease) in accounts receivable increased by 86.9% year-over-year, from $2.69M to $5.02M.